PM Pharma ApS: Financial statements 2022
CVR: 42988197
Source: annual report 2022, Danish Business Authority
17/01/2022 – 31/12/2022
PM Pharma ApS (CVR 42988197) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,007,879 and a net result of DKK 187,612. Equity in the 2022 report amounted to DKK 227,612. The solvency ratio was 42%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,007,879
- Profit/Loss
- DKK 187,612
- Equity
- DKK 227,612
- Total Assets
- DKK 542,233
- Employees
- 2
Official annual report
Keep an eye on PM Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of January 17, 2022, Patrick Munck is registered as director of PM Pharma ApS.
As of January 17, 2022, PM Engineering ApS is registered as an owner of PM Pharma ApS with an ownership share of 100%.
PM Pharma ApS was founded on January 17, 2022.
About PM Pharma ApS
PM Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Installation af industrimaskiner og -udstyr. The management consists of Patrick Munck. The company is owned by PM Engineering ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 3,220,588 and a net result of DKK -19,580 compared with DKK 6,341 the year before. Equity in the 2025 report amounted to DKK 151,479.